🇺🇸 FDA
Patent

US 9018175

3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives

granted A61PA61P1/04A61P1/16

Quick answer

US patent 9018175 (3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives) held by TAKEDA GMBH expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/00, A61P11/02